Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial
Authors:
- Pratima ChowdaryPCPratima Chowdary
- Pantep AngchaisuksiriPAPantep Angchaisuksiri
- Shashikant ApteSAShashikant Apte
- Jan AstermarkJAJan Astermark
- Gary BensonGBGary Benson
- Anthony K C ChanACAnthony K C Chan
- Victor Jiménez YusteVYVictor Jiménez Yuste
- Tadashi MatsushitaTMTadashi Matsushita
- Amalie Rhode Høgh NielsenANAmalie Rhode Høgh Nielsen
- Jameela SatharJSJameela Sathar
- Christopher SuttonCSChristopher Sutton
- Sonata Šaulytė TrakymienėSTSonata Šaulytė Trakymienė
Top Cited Papers
Open Access
- 6 November 2024
- journal article
- research article
- Published by Elsevier in The Lancet Haematology
- Vol. 11 (12) , e891-e904
Abstract
No abstract availableFunding Information
- Novo Nordisk A/S
This publication has 24 references indexed in Scilit:
- Disease and treatment burden of patients with haemophilia entering the explorer6 non‐interventional studyEuropean Journal of Haematology, 2024
- Comparison of thrombotic adverse events in patients treated with factor VIII products and emicizumab using the 2018-2022 US Food and Drug Administration Adverse Event Reporting System dataJournal of Thrombosis and Haemostasis, 2024
- Phase 3 Trial of Concizumab in Hemophilia with InhibitorsNew England Journal of Medicine, 2023
- Nonacog beta pegol (N9‐GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patientsResearch and Practice in Thrombosis and Haemostasis, 2020
- Long-Term Safety and Efficacy of Nonacog Beta Pegol (N9-GP) Administered for at Least 5 Years in Previously Treated Children with Hemophilia BThrombosis and Haemostasis, 2020
- Once‐weekly prophylaxis with 40 IU/kg nonacog beta pegol (N9‐GP) achieves trough levels of >15% in patients with haemophilia B: Pooled data from the paradigm™ trialsHaemophilia, 2018
- Concizumab, an anti‐tissue factor pathway inhibitor antibody, induces increased thrombin generation in plasma from haemophilia patients and healthy subjects measured by the thrombin generation assayHaemophilia, 2017
- Haemophilias A and BThe Lancet, 2003
- Occurrence of hemophilia in the United StatesAmerican Journal of Hematology, 1998
- Variability in the human drug responseThrombosis Research, 1983